Drug–drug interactions involving antipsychotics and antihypertensives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug–drug interactions involving antipsychotics and antihypertensives

Published:2022-04-03 Issue:4 Volume:18 Page:285-298
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Buzea Catalin Adrian¹²^ORCID,Dima Lorena³^ORCID,Correll Christoph U.⁴⁵⁶^ORCID,Manu Peter⁷⁸⁹

Affiliation:

1. Department 5 Internal Medicine, Carol Davila’ University of Medicine and Pharmacy, Bucharest, Romania

2. Cardiology, Clinical Hospital Colentina, Bucharest, Romania

3. Department of Fundamental Disciplines and Clinical Prevention, Faculty of Medicine, Transilvania University of Brasov, Brașov, Romania

4. Department of Child and Adolescent Psychiatry, Charite Universitaetsmedizin, Berlin, Germany

5. Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA

6. Department of Psychiatry, Zucker Hillside Hospital, Northwell Health System, Glen Oaks, NY, USA

7. Department of Psychiatry, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA

8. Department of Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA

9. Medical Services, South Oaks Hospital, Northwell Health System, Amityville, NY, USA

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2022.2086121

Reference137 articles.

1. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls

2. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis

3. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

4. The impact of pharmacological and non‐pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta‐review of meta‐analyses of randomized controlled trials

5. Cardiovascular risk remains high in schizophrenia with modest improvements in bipolar disorder during past decade

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, tolerability, and pharmacokinetics of JX11502MA in Chinese healthy subjects: a first-in-human, randomized, double-blind, placebo-controlled study following single-dose administration;Expert Opinion on Investigational Drugs;2023-12-06

2. The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers;Expert Review of Clinical Pharmacology;2023-09-28

3. Potential Drug-Drug Interactions among Patients with Schizophrenia Spectrum Disorders: Prevalence, Association with Risk Factors, and Replicate Analysis in 2021;Medicina;2023-02-01

4. Drug–drug interactions involving combinations of antipsychotic agents with antidiabetic, lipid-lowering, and weight loss drugs;Expert Opinion on Drug Metabolism & Toxicology;2022-11-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3